The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems might be primed to fend off a worse case, research finds.
Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. Operator: Greetings and welcome to the Vaxart Business Update ...
Food allergies affect 8% of children in the US. Learn to identify the nine most common triggers, recognize symptoms, and create effective management plans.
Serosurveys have expanded our understanding of infectious diseases in Africa, revealing the true burden of pathogens beyond ...
Research conducted at the Hamilton lab has identified several mosquito-borne illnesses that can cause encephalitis ...
This extensive immune cross-reactivity between SARS-CoV-2 antibodies and different antigen groups may play a role in the multi-system disease process of COVID-19, influence the severity of the disease ...
Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.
“Our data showed that while antibody responses declined with each ... “We are now using these stored samples to study cross-reactivity to H5N1 avian influenza, assessing whether prior flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results